Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Taguchi

Showing results (91-100 of 1,190) with videos related to

Pageof 119
Sort By:
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 1, 1979
Absorption rates of cadmium orally administered in a single dose to rats, and the sites in the digestive canal primarily concerned in absorbing CdT Taguchi, S Suzuki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 9, 1999
[Clinical development in gemcitabine and its clinical pharmacological profile]S Tsukagoshi, T Taguchi
Biochimica Et Biophysica Acta|April 22, 1981
Inhibition of anion permeability of sarcoplasmic reticulum vesicles by stilbene derivatives and the identification of an inhibitor-binding proteinM Kasai, T Taguchi
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Upper gastrointestinal tumorsM Ogawa, T Taguchi
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Clinical studies with TNFT Taguchi, Y Sohmura
Biken Journal|June 1, 1987
Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytesY Kimoto, T Taguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Adoptive immunotherapy of malignant disease using LAK cells]Y Kimoto, T Taguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1990
[Gastrointestinal toxicity induced by anticancer drugs--including new antiemetic drugs]K Sampi, T Taguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1987
[Inhibitory effect of human plasma on 17-1A-dependent cellular cytotoxicity]Y Kimoto, T Taguchi
Journal of Biomaterials Science. Polymer Edition|May 11, 2002
Swelling behavior of hyaluronic acid and type II collagen hydrogels prepared by using conventional crosslinking and subsequent additional polymer interactionsT Taguchi, J Tanaka
Pageof 119

Showing results (91-100 of 1,190) with videos related to

Sort By:
Pageof 119
Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene|June 1, 1979
Absorption rates of cadmium orally administered in a single dose to rats, and the sites in the digestive canal primarily concerned in absorbing CdT Taguchi, S Suzuki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 9, 1999
[Clinical development in gemcitabine and its clinical pharmacological profile]S Tsukagoshi, T Taguchi
Biochimica Et Biophysica Acta|April 22, 1981
Inhibition of anion permeability of sarcoplasmic reticulum vesicles by stilbene derivatives and the identification of an inhibitor-binding proteinM Kasai, T Taguchi
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Upper gastrointestinal tumorsM Ogawa, T Taguchi
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Clinical studies with TNFT Taguchi, Y Sohmura
Biken Journal|June 1, 1987
Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytesY Kimoto, T Taguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Adoptive immunotherapy of malignant disease using LAK cells]Y Kimoto, T Taguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1990
[Gastrointestinal toxicity induced by anticancer drugs--including new antiemetic drugs]K Sampi, T Taguchi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1987
[Inhibitory effect of human plasma on 17-1A-dependent cellular cytotoxicity]Y Kimoto, T Taguchi
Journal of Biomaterials Science. Polymer Edition|May 11, 2002
Swelling behavior of hyaluronic acid and type II collagen hydrogels prepared by using conventional crosslinking and subsequent additional polymer interactionsT Taguchi, J Tanaka
Pageof 119